GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96

Analysis of CNS MMGCT with AFP >1000 ng/ml (serum and/or CSF) at diagnosis, treated on trial in SIOP-CNS-GCT-96, revealed an inferior prognosis (32% 5-year progression-free survival) compared with AFP <1000 ng/ml (76%). As this patient group is small, to evaluate a bigger cohort, we revisited...

Descripción completa

Detalles Bibliográficos
Autores principales: Calaminus, Gabriele, Frappaz, Didier, Kortmann, Rolf-Dieter, Ajithkumar, Thankamma, Pietsch, Torsten, Vasiljevic, Alexandre, Ricardi, Umberto, Faure-Conter, Cecile, Timmermann, Beate, Alapetite, Claire, Murray, Matthew J, Garre, Maria Luisa, Nicholson, James C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Germ Cell Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715920/
http://dx.doi.org/10.1093/neuonc/noaa222.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715920/
http://dx.doi.org/10.1093/neuonc/noaa222.266

Ejemplares similares